These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 23791390)
1. Comparison of the effectiveness of Conners' CPT and the CPT-identical pairs at distinguishing between smokers and nonsmokers with schizophrenia. Roth M; Hong LE; McMahon RP; Fuller RL Schizophr Res; 2013 Aug; 148(1-3):29-33. PubMed ID: 23791390 [TBL] [Abstract][Full Text] [Related]
2. Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS). Nuechterlein KH; Green MF; Calkins ME; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Light GA; Radant AD; Seidman LJ; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Swerdlow NR; Tsuang DW; Tsuang MT; Turetsky BI; Braff DL Schizophr Res; 2015 Apr; 163(1-3):38-46. PubMed ID: 25749017 [TBL] [Abstract][Full Text] [Related]
3. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Sacco KA; Termine A; Seyal A; Dudas MM; Vessicchio JC; Krishnan-Sarin S; Jatlow PI; Wexler BE; George TP Arch Gen Psychiatry; 2005 Jun; 62(6):649-59. PubMed ID: 15939842 [TBL] [Abstract][Full Text] [Related]
4. Sustained attention in young people at high risk for schizophrenia. Cosway R; Byrne M; Clafferty R; Hodges A; Grant E; Morris J; Abukmeil SS; Lawrie SM; Miller P; Owens DG; Johnstone EC Psychol Med; 2002 Feb; 32(2):277-86. PubMed ID: 11871372 [TBL] [Abstract][Full Text] [Related]
5. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Barr RS; Culhane MA; Jubelt LE; Mufti RS; Dyer MA; Weiss AP; Deckersbach T; Kelly JF; Freudenreich O; Goff DC; Evins AE Neuropsychopharmacology; 2008 Feb; 33(3):480-90. PubMed ID: 17443126 [TBL] [Abstract][Full Text] [Related]
6. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits. Poltavski DV; Petros T Physiol Behav; 2006 Mar; 87(3):614-24. PubMed ID: 16466655 [TBL] [Abstract][Full Text] [Related]
7. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. Hong LE; Thaker GK; McMahon RP; Summerfelt A; Rachbeisel J; Fuller RL; Wonodi I; Buchanan RW; Myers C; Heishman SJ; Yang J; Nye A Arch Gen Psychiatry; 2011 Dec; 68(12):1195-206. PubMed ID: 21810630 [TBL] [Abstract][Full Text] [Related]
8. Does the Conners' Continuous Performance Test aid in ADHD diagnosis? McGee RA; Clark SE; Symons DK J Abnorm Child Psychol; 2000 Oct; 28(5):415-24. PubMed ID: 11100916 [TBL] [Abstract][Full Text] [Related]
9. Validity of the factor structure of Conners' CPT. Egeland J; Kovalik-Gran I J Atten Disord; 2010 Jan; 13(4):347-57. PubMed ID: 19448149 [TBL] [Abstract][Full Text] [Related]
10. Dimensions of attention impairment and negative symptoms in schizophrenia: a multidimensional approach using the conners continuous performance test in a Spanish population. Sanz JC; Gómez V; Vargas ML; Marín JJ Cogn Behav Neurol; 2012 Jun; 25(2):63-71. PubMed ID: 22543264 [TBL] [Abstract][Full Text] [Related]
11. Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status. Wing VC; Bacher I; Sacco KA; George TP Psychiatry Res; 2011 Aug; 188(3):320-6. PubMed ID: 21669462 [TBL] [Abstract][Full Text] [Related]
12. Sustained attention and planning deficits but intact attentional set-shifting in neuroleptic-naïve first-episode schizophrenia patients. Hilti CC; Delko T; Orosz AT; Thomann K; Ludewig S; Geyer MA; Vollenweider FX; Feldon J; Cattapan-Ludewig K Neuropsychobiology; 2010; 61(2):79-86. PubMed ID: 20016226 [TBL] [Abstract][Full Text] [Related]
13. Cognitive deficits in early-onset schizophrenia spectrum patients and their non-psychotic siblings: a comparison with ADHD. Groom MJ; Jackson GM; Calton TG; Andrews HK; Bates AT; Liddle PF; Hollis C Schizophr Res; 2008 Feb; 99(1-3):85-95. PubMed ID: 18083349 [TBL] [Abstract][Full Text] [Related]
14. Attentional deficits in patients with schizophrenia and in their non-psychotic first-degree relatives. Laurent A; Saoud M; Bougerol T; d'Amato T; Anchisi AM; Biloa-Tang M; Dalery J; Rochet T Psychiatry Res; 1999 Dec; 89(3):147-59. PubMed ID: 10708262 [TBL] [Abstract][Full Text] [Related]
15. Sustained attention deficits among HIV-positive individuals with comorbid bipolar disorder. Posada C; Moore DJ; Deutsch R; Rooney A; Gouaux B; Letendre S; Grant I; Atkinson JH; J Neuropsychiatry Clin Neurosci; 2012; 24(1):61-70. PubMed ID: 22450615 [TBL] [Abstract][Full Text] [Related]
16. Sustained attention deficits in nonpsychotic relatives of schizophrenic patients: a recurrence risk ratio analysis. Chen WJ; Chang CH; Liu SK; Hwang TJ; Hwu HG; Biol Psychiatry; 2004 May; 55(10):995-1000. PubMed ID: 15121483 [TBL] [Abstract][Full Text] [Related]
17. [Vulnerability to schizophrenia. III: Importance and limits of the Identical Pairs Continuous Performance Test]. Laurent A; Rochet T; D'Amato T; Anchisi AM; Daumal M; Favre P; Bougerol T; Dalery J Encephale; 2000; 26(2):48-55. PubMed ID: 10858916 [TBL] [Abstract][Full Text] [Related]
18. Reverse translated and gold standard continuous performance tests predict global cognitive performance in schizophrenia. Bismark AW; Thomas ML; Tarasenko M; Shiluk AL; Rackelmann SY; Young JW; Light GA Transl Psychiatry; 2018 Apr; 8(1):80. PubMed ID: 29643355 [TBL] [Abstract][Full Text] [Related]
19. Why do young women smoke? VI. A controlled study of nicotine effects on attention: pharmacogenetic interactions. Rigbi A; Yakir A; Sarner-Kanyas K; Pollak Y; Lerer B Pharmacogenomics J; 2011 Feb; 11(1):45-52. PubMed ID: 20231857 [TBL] [Abstract][Full Text] [Related]
20. Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous Performance Test. Nieuwenstein MR; Aleman A; de Haan EH J Psychiatr Res; 2001; 35(2):119-25. PubMed ID: 11377441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]